US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% SNDK $1,704.16 ▼-0.92%
FinancialContent

Akili, Inc. - Common Stock (NQ:AKLI)

0.4320 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Akili, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Akili Announces Business Transformation, Focusing on Non-prescription Model
From Akili, Inc.
Via Business Wire
News headline image
Akili Reports Second Quarter 2023 Financial Results and Provides Business Update
From Akili, Inc.
Via Business Wire
News headline image
Akili to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 10 at 4:30 p.m. ET
From Akili, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Where Akili Stands With Analysts ↗
 
Via Benzinga
Expert Ratings for Akili ↗
 
Via Benzinga
News headline image
Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 144.5% to $0.7827. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
It's time for a final look at the biggest pre-market stock movers this week as we check out what's happening on Friday morning! 
Via InvestorPlace
News headline image
EndeavorOTC Elevates ADHD Treatment: Unprecedented Mobile Game Therapy for Adults ↗
Akili Inc (NASDAQ: AKLI) released EndeavorOTC, a new immersive mobile video game treatment clinically proven to improve attention and focus,  
Via Benzinga
News headline image
Akili Releases EndeavorOTCTM Video Game Treatment to Improve Attention in Adults with ADHD
From Akili, Inc.
Via Business Wire
News headline image
Akili to Present Clinical Data from Pivotal Trial of Video Game Treatment in Adolescents with ADHD at 2023 ASCP Annual Meeting and Elevate Psych Congress
From Akili, Inc.
Via Business Wire
News headline image
Akili Reports First Quarter 2023 Financial Results and Provides Business Update
From Akili, Inc.
Via Business Wire
News headline image
Why ClearOne Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket ↗
Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) gained 74.2% to $0.2701 in pre-market trading after gaining around 7% on Monday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based Therapeutic
From PureTech Health plc
Via Business Wire
News headline image
Game-Changing ADHD Treatment: Akili's EndeavorRx Shows Significant Improvement in Adult Attention Functioning ↗
Akili Inc (NASDAQ: AKLI) announced the topline results of the STARS-ADHD-Adult trial evaluating EndeavorRx (AKL-T01) in adults with attention  
Via Benzinga
News headline image
RIVN Stock Alert: Rivian Preps for Georgia Manufacturing Facility ↗
Rivian Automotive (RIVN) stock is up on Wednesday after the company announced it's preparing a Georgia manufacturing facility. 
Via InvestorPlace
News headline image
Why Is Akili (AKLI) Stock Up 21% Today? ↗
Akili (AKLI) stock is gaining on Wednesday after the company's video game treatment showed success in reducing ADHD in adults. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based Therapeutic
From Akili, Inc.
Via Business Wire
News headline image
Akili to Host First Quarter Financial Results Conference Call and Webcast on Thursday, May 11 at 4:30 p.m. ET
From Akili, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Akili Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Akili, Inc.
Via Business Wire
News headline image
Akili to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, March 7 at 4:30 p.m. ET
From Akili, Inc.
Via Business Wire
News headline image
Akili to Participate in the Cowen 43rd Annual Health Care Conference
From Akili, Inc.
Via Business Wire
News headline image
Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference
From Akili, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Pivotal Trial of EndeavorRxⓇ in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes
From Akili, Inc.
Via Business Wire
News headline image
Morgan Stanley Initiates Coverage On This Digital Therapeutics Stock With Attractive View ↗
 
Via Benzinga
< Previous 1 2 3 4 5 Next >